NCT02680756View on ClinicalTrials.gov

Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

January 31, 2019

Conditions
Anemia, Iron-DeficiencyInflammatory Bowel DiseaseCrohn's Disease
Interventions
DRUG

Ferric Maltol

DRUG

Ferric Carboxy Maltose

Trial Locations (44)

Unknown

Dothan

Tucson

Gainesville

Hollywood

Chevy Chase

Saint Paul

St Louis

Great Neck

Lima

Germantown

Nashville

Beaumont

Houston

San Antonio

Bountiful

Bellevue

Seattle

Ghent

Clichy

Lille

Lyon

Saint-Etienne

Salouël

Vandœuvre-lès-Nancy

Berlin

Dresden

Hamburg

Herne

Jena

Leipzig

Lübeck

Lüneburg

Minden

Oldenburg

Schweinfurt

Budapest

Miskolc

Szeged

Barcelona

Córdoba

Girona

Madrid

Santiago de Compostela

Valencia

Sponsors
All Listed Sponsors
lead

Shield Therapeutics

INDUSTRY

NCT02680756 - Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD | Biotech Hunter | Biotech Hunter